Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 3 | ClinicalTrials |
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 3 | ClinicalTrials |
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 1 | ClinicalTrials |
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 2 | ClinicalTrials |
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 3 | ClinicalTrials |
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 2 | ClinicalTrials |
| alpha-Mannosidosis; Mannosidase Deficiency Diseases | Phase 3 | ClinicalTrials |
CONTENTS